MoonLake Immunotherapeutics
MLTX
#3800
Rank
NZ$4.08 B
Marketcap
$64.59
Share price
3.67%
Change (1 day)
-12.23%
Change (1 year)

EPS for MoonLake Immunotherapeutics (MLTX)

EPS in 2023 (TTM): -$1.93

According to MoonLake Immunotherapeutics's latest financial reports the company's current EPS (TTM) is -$1.97. In 2022 the company made an earnings per share (EPS) of -$2.49.

EPS history for MoonLake Immunotherapeutics from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.93-22.6%
2022-$2.49